drugset / Trial / NCT02016625

Investigation of Potential Drug-drug Interactions Between Faldaprevir and the Immunosuppressant Drugs Cyclosporine or Tacrolimus

NCT02016625

Phase 1 Completed 32 enrolled Boehringer Ingelheim
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The primary objective of this trial is to investigate the effect of multiple-dose faldaprevir (FDV) on the single-dose pharmacokinetics of cyclosporine or tacrolimus

Timeline

Start
2013-12
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide
Subject Faldaprevir Small molecule
Subject Tacrolimus Small molecule

Indications

No indication recorded.